fashion -WSS

fashion

author：focus 2025-09-28 00:50:54 - browse：734

parts of a dna helix fades while a segment stays solid — Adobe

Flagship Pioneering, the venture capital firm behind Moderna, on Tuesday unveiled a new biotech called Quotient Therapeutics that will have offices in Massachusetts and the United Kingdom.

Quotient, which was founded last year and had operated in stealth mode, wants to develop drugs that target illnesses caused by genetic changes that occur as people age. Those conditions include immune diseases, cancers, neurodegenerative illnesses, and cardiometabolic disorders, such as heart attacks, strokes and diabetes.

With an initial of $50 million from the venture firm Flagship Pioneering, Quotient will be located in Cambridge, Mass., and Cambridge, England. Most of the academic co-founders work in the UK city. Quotient is the first Flagship-backed biotech that will be based in both countries.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： What drug price negotiations mean for Medicare Part D

hotspot

WSS

What American doctors can learn from their Israeli counterparts

'Make People Better': The CRISPR babies story you probably don't know

Are embryos people? Reproductive medicine's future depends on the answer

Virtual repurposing can help discover new uses for existing drugs

A new House health package & hospitals’ new site

How to fix cancer clinical trials' diversity problem

hotspot

fashion

Wikipedia

Apple is now the first public company to be valued at $3 trillion

Children’s Hospital revives plan for pedestrian bridge

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Virtual repurposing can help discover new uses for existing drugs

How one medical school became remarkably diverse

Medicaid rebukes states for mistakenly disenrolling children

DIEP, the 'gold standard' of breast reconstruction, is under threat

How to fix cancer clinical trials' diversity problem

Hollywood unions extend contract negotiations for actors

How to fix cancer clinical trials' diversity problem

focus

Medicaid rebukes states for mistakenly disenrolling children

Advances in CAR

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Stem cell treatment guidelines are released by FDA

Children’s Hospital revives plan for pedestrian bridge

Virtual repurposing can help discover new uses for existing drugs

explore

hotspot

hotspot

focus